|
|
Ken Stuart, Reto Brun, Simon Croft, Alan Fairlamb, Ricardo E. Gürtler, Jim McKerrow, Steve Reed, Rick Tarleton
J Clin Invest. 2008;
118(4):1301
doi:10.1172/JCI33945
Abstract |
Full text
| PDF
K
inetoplastids are a group of flagellated protozoans that include the species Trypanosoma and Leishmania, which are human pathogens with devastating health and economic effects. The sequencing of the genomes of some of these species has highlighted their genetic relatedness and underlined differences in the diseases that they cause. As we discuss in this Review, steady progress using a combination of molecular, genetic, immunologic, and clinical approaches has substantially increased understanding of these pathogens and important aspects of the diseases that they cause. Consequently, the paths for developing additional measures to control these “neglected diseases” are becoming increasingly clear, and we believe that the opportunities for developing the drugs, diagnostics, vaccines, and other tools necessary to expand the armamentarium to combat these diseases have never been better.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(25)
| Title and authors |
Publication |
Year |
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. 2. Tadalafil analogs
Stefan O. Ochiana, Alden Gustafson, Nicholas D. Bland, Cuihua Wang, Michael J. Russo, Robert K. Campbell, Michael P. Pollastri
|
Bioorganic & Medicinal Chemistry Letters
|
2012 |
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. 1. Sildenafil analogs
Cuihua Wang, Trent D. Ashton, Alden Gustafson, Nicholas D. Bland, Stefan O. Ochiana, Robert K. Campbell, Michael P. Pollastri
|
Bioorganic & Medicinal Chemistry Letters
|
2012 |
Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
Inmaculada Ramírez-Macías, Clotilde Marín, Hakima Es-Samti, Antonio Fernández, Juan José Guardia, Huda Zentar, Ahmad Agil, Rachid Chahboun, Enrique Alvarez-Manzaneda, Manuel Sánchez-Moreno
|
Parasitology International
|
2012 |
Synthesis, Biological Evaluation and Structure-Activity Relationships of N-Benzoyl-2-hydroxybenzamides as Agents Active against P. falciparum (K1 strain), Trypanosomes, and Leishmania
Jozef Stec, Qingqing Huang, Marco Pieroni, Marcel Kaiser, Alina Fomovska, Ernest Mui, William H Witola, Samuel Bettis, Rima McLeod, Reto Brun
|
J. Med. Chem.
|
2012 |
Identification of Inhibitors of the Leishmania cdc-Related Protein Kinase CRK3
Laura A. T. Cleghorn, Andrew Woodland, Iain T. Collie, Leah S. Torrie, Neil Norcross, Torsten Luksch, Chido Mpamhanga, Roderick G. Walker, Jeremy C. Mottram, Ruth Brenk
|
ChemMedChem
|
2011 |
An evolutionary analysis of trypanosomatid GP63 proteases
Lina Ma, Kaifu Chen, Qingshu Meng, Qingyou Liu, Petrus Tang, Songnian Hu, Jun Yu
|
Parasitol Res
|
2011 |
Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis)
Fadoua Bouchikhi, Fabrice Anizon, Reto Brun, Pascale Moreau
|
Bioorganic & Medicinal Chemistry Letters
|
2011 |
Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
Victoria C. Smith, Laura A. T. Cleghorn, Andrew Woodland, Daniel Spinks, Irene Hallyburton, Iain T. Collie, N. Yi Mok, Suzanne Norval, Ruth Brenk, Alan H. Fairlamb
|
ChemMedChem
|
2011 |
Cloning, expression, characterization, and inhibition studies on Trypanothione Synthetase, a drug target enzyme, from <i>Leishmania donovani</i>
Prakash Saudagar,, Vikash Kumar Dubey,
|
Biological Chemistry
|
2011 |
Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
Stephen Patterson, Magnus S. Alphey, Deuan C. Jones, Emma J. Shanks, Ian P. Street, Julie A. Frearson, Paul G. Wyatt, Ian H. Gilbert, Alan H. Fairlamb
|
J. Med. Chem.
|
2011 |
|